BRAIN METASTASES FROM HER2 AND BREAST CANCER

Clinical trials for BRAIN METASTASES FROM HER2 AND BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new BRAIN METASTASES FROM HER2 AND BREAST CANCER trials appear

Sign up with your email to follow new studies for BRAIN METASTASES FROM HER2 AND BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial targets Tough-to-Treat HER2 cancers, including brain spread

Disease control Recruiting now

This is an early-stage study to find a safe and effective dose of a new drug called IAM1363 for people with advanced cancers that have specific changes in a protein called HER2. The trial will enroll about 243 adults whose cancer has worsened after standard treatments, including …

Matched conditions: BRAIN METASTASES FROM HER2 AND BREAST CANCER

Phase: PHASE1 • Sponsor: Iambic Therapeutics, Inc • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

BRAIN METASTASES FROM HER2 AND BREAST CANCER

Get alerted when new BRAIN METASTASES FROM HER2 AND BREAST CANCER trials appear

New drug trial targets Tough-to-Treat HER2 cancers, including brain spread